Subject    :    [2017 Apr;41(2)] Role of NO/VASP Signaling Pathway against Obesity-Related Inflammation and Insulin Resistance
Writer KDA
Date 2017-07-06 10:58:54 Hit 1,872
Diabetes Metab J. 2017 Apr;41(2):89-95. English.
Published online Nov 15, 2016.  https://doi.org/10.4093/dmj.2017.41.2.89 
Copyright © 2017 Korean Diabetes Association
   
Role of NO/VASP Signaling Pathway against Obesity-Related Inflammation and Insulin Resistance
Yu Mi Kang,1 Francis Kim,2 and Woo Je Lee1
1Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
2Department of Medicine, Diabetes and Obesity Center of Excellence, University of Washington, Seattle, WA, USA.

Corresponding author: Woo Je Lee. Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Korea. Email: lwjatlas@amc.seoul.kr 
 
Received September 08, 2016; Accepted October 26, 2016.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

 
Abstract

Obesity has quickly become a worldwide pandemic, causing major adverse health outcomes such as dyslipidemia, type 2 diabetes mellitus, cardiovascular disease and cancers. Obesity-induced insulin resistance is the key for developing these metabolic disorders, and investigation to understand the molecular mechanisms involved has been vibrant for the past few decades. Of these, low-grade chronic inflammation is suggested as a critical concept in the development of obesity-induced insulin resistance, and the anti-inflammatory effect of nitric oxide (NO) signaling has been reported to be linked to improvement of insulin resistance in multiple organs involved in glucose metabolism. Recently, a body of evidence suggested that vasodilatory-stimulated phosphoprotein (VASP), a downstream mediator of NO signaling plays a crucial role in the anti-inflammatory effect and improvement of peripheral insulin resistance. These preclinical studies suggest that NO/VASP signaling could be an ideal therapeutic target in the treatment of obesity-related metabolic dysfunction. In this review, we introduce studies that investigated the protective role of NO/VASP signaling against obesity-related inflammation and insulin resistance in various tissues.

   
Keywords:
Adipose tissue; Chronic inflammation; Endothelium, vascular; Insulin resistance; Liver; Macrophages; Nitric oxide; Obesity; Vasodilator-stimulated phosphoprotein

Articles - Reviews in DMJ
No. Subject Date Hit ↓
Notice : [2017 Jun;41(3)] Satisfaction Survey on Information Technology-Based Glucose Monitoring System Targeting Diabetes Mellitus in Private Local Clinics in Korea [2017 Jun;41(3)] Satisfaction Survey on Information Technology-Based... 2017-07-06 2,026
Notice : [2017 Jun;41(3)] The Effect of 12 Weeks Aerobic, Resistance, and Combined Exercises on Omentin-1 Levels and Insulin Resistance among Type 2 Diabetic Middle-Aged Women [2017 Jun;41(3)] The Effect of 12 Weeks Aerobic, Resistance, and Com... 2017-07-06 2,047
Notice : [2017 Jun;41(3)] Impact of Gender on the Association between Low Serum Prolactin and Left Ventricular Mass in Subjects with Prediabetes [2017 Jun;41(3)] Impact of Gender on the Association between Low Ser... 2017-07-06 1,911
Notice : [2017 Jun;41(3)] Physician-Directed Diabetes Education without a Medication Change and Associated Patient Outcomes [2017 Jun;41(3)] Physician-Directed Diabetes Education without a Med... 2017-07-06 1,817
Notice : [2017 Jun;41(3)] Knowledge, Attitude, and Practice of Iranian Internists Regarding Diabetes: A Cross Sectional Study [2017 Jun;41(3)] Knowledge, Attitude, and Practice of Iranian Intern... 2017-07-06 1,864
Notice : [2017 Jun;41(3)] Comparison of Antidiabetic Regimens in Patients with Type 2 Diabetes Uncontrolled by Combination Therapy of Sulfonylurea and Metformin: Results of the MOHAS Disease Registry in Korea [2017 Jun;41(3)] Comparison of Antidiabetic Regimens in Patients wit... 2017-07-06 1,912
Notice : [2017 Jun;41(3)] Diabetes Prevention in Australia: 10 Years Results and Experience [2017 Jun;41(3)] Diabetes Prevention in Australia: 10 Years Results ... 2017-07-06 1,854
Notice : [2017 Jun;41(3)] Comprehensive Approach for Managing the Older Person with Diabetes Mellitus [2017 Jun;41(3)] Comprehensive Approach for Managing the Older Perso... 2017-07-06 1,752
Notice : [2017 Apr;41(2)] A Cutoff for Age at Menarche Predicting Metabolic Syndrome in Egyptian Overweight/Obese Premenopausal Women [2017 Apr;41(2)] A Cutoff for Age at Menarche Predicting Metabolic S... 2017-07-06 1,762
Notice : [2017 Apr;41(2)] Addition of Ipragliflozin to Metformin Treatment in Korean Patients with Type 2 Diabetes Mellitus: Subgroup Analysis of a Phase 3 Trial [2017 Apr;41(2)] Addition of Ipragliflozin to Metformin Treatment in... 2017-07-06 1,877
Notice : [2017 Apr;41(2)] Lipid Abnormalities in Type 2 Diabetes Mellitus Patients with Overt Nephropathy [2017 Apr;41(2)] Lipid Abnormalities in Type 2 Diabetes Mellitus Pat... 2017-07-06 1,824
Notice : [2017 Apr;41(2)] Regulating Hypothalamus Gene Expression in Food Intake: Dietary Composition or Calorie Density? [2017 Apr;41(2)] Regulating Hypothalamus Gene Expression in Food Int... 2017-07-06 1,847
Notice : [2017 Apr;41(2)] Association between Blood Mercury Level and Visceral Adiposity in Adults [2017 Apr;41(2)] Association between Blood Mercury Level and Viscera... 2017-07-06 1,833
Notice : [2017 Apr;41(2)] Diabetes Camp as Continuing Education for Diabetes Self-Management in Middle-Aged and Elderly People with Type 2 Diabetes Mellitus [2017 Apr;41(2)] Diabetes Camp as Continuing Education for Diabetes ... 2017-07-06 1,927
Notice : [2017 Apr;41(2)] Role of NO/VASP Signaling Pathway against Obesity-Related Inflammation and Insulin Resistance [2017 Apr;41(2)] Role of NO/VASP Signaling Pathway against Obesity-R... 2017-07-06 1,872
Notice : [2017 Apr;41(2)] A Clinical Practice Guideline to Guide a System Approach to Diabetes Care in Hong Kong [2017 Apr;41(2)] A Clinical Practice Guideline to Guide a System App... 2017-07-06 1,842
181 [2017 Feb;41(1)] Exenatide versus Insulin Lispro Added to Basal Insu... 2017-03-23 3,409
180 [2017 Feb;41(1)] Serum Calcium and the Risk of Incident Metabolic Sy... 2017-03-23 3,413
179 [2017 Feb;41(1)] Relationship between Regional Body Fat Distribution... 2017-03-23 3,601
178 [2017 Feb;41(1)] Application of the 2013 American College of Cardiol... 2017-03-23 3,597
177 [2017 Feb;41(1)] Practical Focus on American Diabetes Association/Eu... 2017-03-23 3,464
176 [2017 Feb;41(1)] Efficacy of Moderate Intensity Statins in the Treat... 2017-03-23 3,566
175 [2017 Feb;41(1)] Nuclear Receptors Resolve Endoplasmic Reticulum Str... 2017-03-23 3,465
174 [2017 Feb;41(1)] My Sweetheart Is Broken: Role of Glucose in Diabeti... 2017-03-23 3,613
173 [2016 Dec;40(6)] Investigating Susceptibility to Diabetes Using Feat... 2017-01-02 3,719
172 [2016 Dec;40(6)] Clinical Course and Risk Factors of Diabetic Retino... 2017-01-02 3,666

목록

Gets the previous 5 pages.   Go to previous page.  [1]   2   3   4   5     Go to next page. Gets the next  5 pages.